Carol Hyndes

4 weeks ago | slatersentinel.com | Carol Hyndes

Brant Point Investment Management LLC grew its holdings in Alphabet Inc. (NASDAQ:GOOG – Free Report) by 20.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,940 shares of the information services provider’s stock after purchasing an additional 3,000 shares during the quarter. Brant Point Investment Management LLC’s holdings in Alphabet were worth $3,416,000 at the end of the most recent reporting period.

4 weeks ago | slatersentinel.com | Carol Hyndes

Alexis Investment Partners LLC bought a new stake in shares of Applied Materials, Inc. (NASDAQ:AMAT – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 8,951 shares of the manufacturing equipment provider’s stock, valued at approximately $1,461,000. Applied Materials makes up about 0.7% of Alexis Investment Partners LLC’s investment portfolio, making the stock its 22nd largest position.

4 weeks ago | slatersentinel.com | Carol Hyndes

Capital International Ltd. CA grew its stake in shares of Linde plc (NASDAQ:LIN – Free Report) by 10.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 44,182 shares of the basic materials company’s stock after acquiring an additional 4,031 shares during the quarter. Capital International Ltd. CA’s holdings in Linde were worth $18,498,000 as of its most recent SEC filing.

4 weeks ago | slatersentinel.com | Carol Hyndes

Calian Group Ltd. (OTCMKTS:CLNFF) Short Interest Up 103.5% in March Calian Group Ltd. (OTCMKTS:CLNFF – Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 111,300 shares, a growth of 103.5% from the March 15th total of 54,700 shares.

4 weeks ago | slatersentinel.com | Carol Hyndes

Abbott Laboratories (NYSE:ABT – Free Report) – Investment analysts at William Blair boosted their Q3 2025 EPS estimates for shares of Abbott Laboratories in a research note issued on Thursday, April 17th. William Blair analyst M. Andrew now expects that the healthcare product maker will earn $1.33 per share for the quarter, up from their previous forecast of $1.32. The consensus estimate for Abbott Laboratories’ current full-year earnings is $5.14 per share.